Zydus Lifesciences stock faces resistance at ₹920 and ₹940, with a downtrend likely to continue despite recent recovery.
The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...
17h
ET Now on MSN'Accept this challenge…’ - Ashwini Vaishnaw has a task for Infosys, TCS and Wipro to make India ‘product-driven nation’Union Information and Technology Minister Ashwini Vaishnaw has has called out TCS, Infosys, and Wipro. The IT Minister has ...
Get all latest & breaking news on Moneycontrol Pro. Watch videos, top stories and articles on Moneycontrol Pro at moneycontrol.com.
Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, offering a safer and more affordable treatment option. Mar 05, 2025 15:16 Zydus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results